Andreessen Horowitz backs Synonym’s bio-manufacturing facilities • ZebethMedia
Armed with $6.3 million in new pre-seed capital, Synonym Biotechnologies has begun the development phase for its first productized bio-manufacturing facilities for non-pharmaceutical applications. Edward Shenderovich and Joshua Lachter started the company in January 2022 to develop, finance and build commercial-scale bio-manufacturing facilities to provide synthetic biology producers of all size with flexible production capacity […]